Overview

CD34 is a glycosylated transmembrane protein that serves as established marker of hematopoietic stem and progenitor cells. Umbilical Cord Blood (CB) is a rich source of CD34+ hematopoietic stem and progenitor cells (HSPCs), a rare and primitive population of multipotent cells that can give rise to all blood cell types.

Due to their superior proliferation, differentiation, and self-renewal, cord blood-derived CD34+ stem cells are an advantageous choice for a wide range of research including genome editing, immune regulation, hematopoiesis, and regenerative medicine.

Our CD34+ stem cells are derived from ethically sourced human umbilical cord blood collected using IRB protocols and/or in accordance with local, state and federal requirements. We use positive immunomagnetic techniques to isolate the cells resulting in a highly enriched population of CD34+ cells with exceptional viability.

What To Expect

• > 95% Viability
• > 90% Purity
• Negative for HIV-1, HIV-2, Hepatitis B, Hepatitis C
• Certificate of Analysis
• Responsive Customer Support

Key Features

• For Research Use Only
• Various Cell Counts Available
• Single and Pooled Donor Options
• CD34+ cells frozen in 10% DMSO cryopreservation medium
• Store in liquid nitrogen vapor phase
• Cells Stable at < -135^oC for one year from receipt

Available Cell Counts

• 750,000 Cells – Single Donor
• 1 Million Cells – Single Donor
• 2 Million Cells - Single Donor
• 2 Million Cells – Pooled Donor

Potential Research Applications

• Molecular Genetics
• Angiogenesis
• Regenerative Medicine
• Immune Diseases
• Gene Editing/CRISPR
• Validating Expansion Technology

Benefits of Using CD34+

CD34+ cells derived from umbilical cord blood (UCB) offer several advantages compared to those obtained from other sources of CD34+ cells, including:

• Non-invasive collection
• More Naïve/primitive than other sources
• Greater proliferation